SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy ($MULN) is trending as a speculative Solana-based meme coin that has polarized the community, with some investors betting on parabolic recovery plays while many others label it a continuation of the negative sentiment surrounding the original Mullen Automotive stock. Participants are actively debating the token's extreme volatility and its status as a high-risk "pump and dump" project versus a community-driven attempt to recover historical investment losses.

XDC Network is an enterprise-ready hybrid Blockchain technology company optimized for international trade and finance. The XDC Network is powered by the native coin called XDC. The XDC protocol is architected to support smart contracts, 2000TPS, 2seconds transaction time, KYC to Masternodes (Validator Nodes). The XDC Chain (XinFin Digital Contract) uses XinFin Delegated Proof of Stake (XDPoS), with the intending to create a ‘highly-scalable, secure, permission, and commercial grade’ blockchain network. XinFin mainnet token XDC and also creates an opportunity to utilize the XinFin’s real-world use-cases such as TradeFinex.org, helps small and medium businesses or institutions originate their own financial requirements in a digital, fully structured manner so that they can distribute it to the bank or non-bank funders themselves using a common distribution standard.

XinFin Network

XinFin Network (XDC) is currently trending as a focus for utility-focused investors who are heavily discussing its potential role in global trade finance, ISO 20022 compliance, and institutional adoption. The community is actively debating the coin's long-term value, with many participants using current price consolidation to accumulate positions while comparing its growth potential against other major infrastructure-oriented tokens.

Linea is the Layer 2 built from first principles to strengthen Ethereum and the entire ETH economy. Every aspect of its design—from its productive ETH burn mechanics, and capital efficient native yield, to its underlying Ethereum-equivalent zk tech—amplifies the value and utility of Ethereum Mainnet. All of this is backed by the largest ecosystem fund in the space, managed by the most trusted Ethereum builders. With institutional-grade infrastructure, and deep integration across DeFi, Linea is the best chain for ETH capital, where every transaction and every block strengthens Ethereum. Linea is where Ethereum wins.

Linea

The Linea community is intensely debating the project's potential integration with SWIFT, with many investors viewing the development as a major institutional catalyst and a strategic play within the Ethereum ecosystem. While some are optimistic about long-term value and the project's institutional backing, others express significant frustration over volatile price action, token unlock concerns, and communication gaps from the team.

USDX is the crypto-backed native stablecoin of the Kava DeFi hub.

USDX Stablecoin

The USDX stablecoin is currently at the center of investor focus as the market navigates the fallout from high-profile DeFi platform collapses and ongoing regulatory efforts by stablecoin issuers to integrate more deeply into the traditional U.S. financial system. Community members are actively analyzing the coin's stability and risk profile, while market participants weigh broader sentiment regarding stablecoin reliability amid recent volatility.

Maul Coin

Maul Coin is trending as community members rally behind what they describe as an organic, developer-backed project while pushing for increased social media engagement and chart listings. Discussions are heavily focused on the coin's rapid growth and the potential for a parabolic breakout as the community aims to reach higher market capitalization milestones.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is gaining momentum following its strategic acquisition of StereoLabs, a move that establishes the company as a unified sensing and perception platform for Physical AI by integrating lidar with high-performance 3D vision. The community is actively discussing the stock's improved path to profitability and strengthened competitive position in the robotics, industrial, and smart infrastructure sectors.

CSX Corp. engages in the provision of rail-based freight transportation services. Its services include rail service, the transport of intermodal containers and trailers, rail-to-truck transfers, and bulk commodity operations. It operates through Rail and Trucking segments. The Rail segment provides rail-based transportation services including traditional rail service and the transport of intermodal containers. The Trucking segment relates to quality carriers. The company was founded in 1827 and is headquartered in Jacksonville, FL.

CSX Corp.

CSX Corp. is currently trending amid increased volatility following a mixed earnings report and the disclosure of a subpoena from the SEC related to previous accounting restatements and performance metrics. Investors are actively debating the company's long-term outlook, weighing potential M&A speculation, dividend hikes, and fleet modernization efforts against concerns over weak coal demand, operational disruptions, and a competitive landscape that has industry participants closely watching for further consolidation.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is capturing attention as community members debate its long-term potential as a high-performance Layer 1 blockchain, with many actively staking their holdings and pointing to ecosystem growth as a catalyst for future gains. Despite recent market volatility, sentiment remains split between those accumulating at lower prices as a generational wealth opportunity and skeptics concerned about supply dilution.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

Investors are rallying around RETIRE as a community-driven alternative to traditional retirement systems, promoting the token as an 'on-chain 401(k)' for achieving financial independence. The project is seeing active discussion regarding its potential for long-term growth and its ability to empower holders to take control of their financial future.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

General Motors is trending as investors digest a massive $6 billion impairment charge related to the company's strategic EV pullback and restructuring in China. Despite these significant write-downs, the stock remains a focal point for community debate, balancing enthusiasm over record-high performance and shareholder-friendly capital returns against concerns regarding long-term demand for new vehicles and the competitive threats posed by Chinese automakers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>IMUX shares have consistently traded above $1 since February 27.</li><li>The company appointed Jon Congleton, CEO of Mineralys Therapeutics, to its board of directors on Tuesday.</li><li>It recently closed a private placement of up to $400 million to support late-stage trials for the treatment of multiple sclerosis.</li></ul>Shares of Immunic, Inc (IMUX) gained around 7% on Wednesday after the company said it had regained compliance with Nasdaq’s listing rules on March 26.The firm regained compliance after the stock closed at or above $1 for at least 20 consecutive business days. The update removes concerns about a potential delisting from the Nasdaq Capital Market.<a href="https://stocktwits.com/symbol/IMUX">IMUX shares</a> have consistently&nbsp;traded above $1 since February 27.On Tuesday, the company appointed Jon Congleton, CEO of Mineralys Therapeutics, to its board of directors.&nbsp;<h2 class="st-heading-2">Immunic Secures Patent And Raises $400 Million</h2>Last month, the European Patent Office granted Immunic a key patent covering dosing regimens for its lead drug, Vidofludimus Calcium, to treat patients with&nbsp;multiple sclerosis. The protection is expected to last until 2038, with a potential extension to 2043.&nbsp;The patent broadly covers multiple forms of the drug, ensuring strong exclusivity across Europe and building on earlier approval from the United States Patent and Trademark Office.The company also closed a private placement of up to $400 million, led by BVF Partners. Immunic secured $200 million upfront, with additional funding tied to future warrants. The company said the funds will support late-stage trials for multiple sclerosis, aimed at helping slow disease progression.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits remained in the ‘bearish’ zone over the past 24 hours.One user highlighted the potential for a reverse share split.<stembedurl>https://stocktwits.com/ccledez/message/649165039</stembedurl>Another user was bullish about Congleton’s appointment.<stembedurl>https://stocktwits.com/Mvvh1987/message/649022575</stembedurl>Year-to-date, the stock has gained more than 113%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

IMUX Stock Jumps 6% Pre-Market Today – Here’s The Latest Update On Its Compliance With Nasdaq Listing Rules 

Shares of Immunic, Inc (IMUX) gained around 6% in pre-market trading on Wednesday after the company said it had regained compliance with Nasdaq’s listing rules on March 26.

Equity

The company regained compliance after the stock closed at or above $1 for at least 20 consecutive business days.

Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement

Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire NEW YORK, April 1, 2026 NEW YORK, April 1, 2026 /PRNewswire/ -- Immunic, Inc.(Nasdaq: IMUX),a late-stage biotechnology company pioneering the...

Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton

Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton Immunic Strengthens Its Board of Directors with the Appointment of Seasoned...

Immunic (NASDAQ:IMUX) Earns Buy Rating from Analysts at Guggenheim

Guggenheim initiated coverage on shares of Immunic in a research report on Tuesday. They issued a "buy" rating and a $7.00 price objective for the company...

Immunic, Inc. (NASDAQ:IMUX) Given Average Recommendation of "Buy" by Brokerages

Immunic, Inc. (NASDAQ:IMUX - Get Free Report) has been assigned an average rating of "Buy" from the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have given a buy recommendation and...

Immunic Conference: Transformative 2026 Ahead With Pivotal MS Data Due Late Year, NDA Next

Immunic (NASDAQ:IMUX) executives outlined what they described as a transformative 2026, with pivotal data expected late in the year for the company's lead multiple sclerosis (MS) candidate...

Immunic Details Vidofludimus Calcium MS Strategy, Phase III Timeline at Leerink Conference

Immunic (NASDAQ:IMUX) executives outlined their multiple sclerosis (MS) development strategy and commercial thinking for vidofludimus calcium during a session at the Leerink Partners Global...

Short Interest in Immunic, Inc. (NASDAQ:IMUX) Rises By 14.5%

Immunic, Inc. (NASDAQ:IMUX - Get Free Report) saw a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 7,579,660 shares, a growth of...

Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium

Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for...

Immunic to Participate in Investor Conferences in March

Immunic to Participate in Investor Conferences in March Immunic to Participate in Investor Conferences in March PR Newswire NEW YORK, March 3, 2026 NEW YORK, March 3, 2026 /PRNewswire/ -- Immunic...

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on multiple sclerosis, celiac disease and other neurologic and gastrointestinal disorders. The firm's products include IMU-838, IMU-856, and IMU-381. The company was founded in 2016 and is headquartered in New York, NY.

Immunic Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

IMUX
Immunic Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest IMUX News

IMUXImmunic Inc